1. Home
  2. DLTH vs MDWD Comparison

DLTH vs MDWD Comparison

Compare DLTH & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duluth Holdings Inc. Class B

DLTH

Duluth Holdings Inc. Class B

N/A

Current Price

$4.37

Market Cap

154.7M

ML Signal

N/A

Logo MediWound Ltd.

MDWD

MediWound Ltd.

N/A

Current Price

$13.31

Market Cap

162.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DLTH
MDWD
Founded
1989
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
154.7M
162.2M
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
DLTH
MDWD
Price
$4.37
$13.31
Analyst Decision
Hold
Strong Buy
Analyst Count
2
6
Target Price
$5.00
★ $30.67
AVG Volume (30 Days)
55.7K
★ 90.6K
Earning Date
12-15-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 64.12
N/A
EPS
★ 0.23
N/A
Revenue
★ $565,184,000.00
N/A
Revenue This Year
N/A
$39.60
Revenue Next Year
$3.12
$34.34
P/E Ratio
$19.15
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.02
$11.80
52 Week High
$5.09
$19.70

Technical Indicators

Market Signals
Indicator
DLTH
MDWD
Relative Strength Index (RSI) 65.29 56.96
Support Level $3.82 $12.76
Resistance Level $4.77 $14.06
Average True Range (ATR) 0.15 0.54
MACD 0.05 0.20
Stochastic Oscillator 86.51 75.34

Price Performance

Historical Comparison
DLTH
MDWD

About DLTH Duluth Holdings Inc. Class B

Duluth Holdings Inc is an apparel brand in the United States. The company offers shirts, pants, and casual wear for men and women under brands like Alaskan Hardgear, Armachillo, Ballroom, Cab Commander, Crouch Gusset, Dry on the Fly, Duluth Trading Co, Duluthflex, Fire Hose, Longtail T, No Polo Shirt, No Yank, Wild Boar, and others. The Company's revenue consists of the sale of apparel, footwear, and hard goods. The company operates in a single operating segment.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: